Swati Tomar

Swati Tomar

Auto-generated profile, based on publicly available information

Swati Tomar

Cardiovascular Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University Singapore (S.T., D.C.K., C.K.C., L.H.G., R.F.).

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
STSwati Tomar
Swati Tomar
RSRaman Sethi
Raman Sethi
GSGangadhara Sundar
Gangadhara Sundar
TQThuan Chong Quah
Thuan Chong Quah
BQBoon Long Quah
Boon Long Quah
PLPoh San Lai
Poh San Lai
Retinoblastoma (RB) is a rare childhood malignant disorder caused by the biallelic inactivation of RB1 gene. Early diagnosis and identification of carriers of heritable RB1 mutations can improve disease outcome and management. In this study, mutational analysis was conducted on fifty-nine matched tumor and peripheral blood samples from 18 bilateral and 41 unilateral unrelated RB cases by a combinatorial approach of Multiplex Ligation-dependent Probe Amplification (MLPA) assay, deletion screening, direct sequencing, copy number gene dosage analysis and methylation assays. Screening of both blood and tumor samples yielded a mutation detection rate of 94.9% (56/59) while only 42.4% (25/59) of mutations were detected if blood samples alone were analyzed. Biallelic mutations were observed in 43/59 (72.9%) of tumors screened. There were 3 cases (5.1%) in which no mutations could be detected and germline mutations were detected in 19.5% (8/41) of unilateral cases. A total of 61 point mutations were identified, of which 10 were novel. There was a high incidence of previously reported recurrent mutations, occurring at 38.98% (23/59) of all cases. Of interest were three cases of mosaic RB1 mutations detected in the blood from patients with unilateral retinoblastoma. Additionally, two germline mutations previously reported to be associated with low-penetrance phenotypes: missense-c.1981C>T and splice variant-c.607+1G>T, were observed in a bilateral and a unilateral proband, respectively. These findings have implications for genetic counselling and risk prediction for the affected families. This is the first published report on the spectrum of mutations in RB patients from Singapore and shows that further improved mutation screening strategies are required in order to provide a definitive molecular diagnosis for every case of RB. Our findings also underscore the importance of genetic testing in supporting individualized disease management plans for patients and asymptomatic family members carrying low-penetrance, germline mosaicism or heritable unilateral mutational phenotypes.

20 April 2015 in Head & Neck
Verified
Journal Article
Closed access
PDF file
STSwati Tomar
Swati Tomar
CGChristian A. Graves
Christian A. Graves
DADiego Altomare
Diego Altomare
SKSangeeta Kowli
Sangeeta Kowli
SKSusannah Kassler
Susannah Kassler
LPLucia Pirisi
Lucia Pirisi

13 May 2019 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
STSwati Tomar
Swati Tomar
VMVikaesh Moorthy
Vikaesh Moorthy
RSRaman Sethi
Raman Sethi
JCJosiah Chai
Josiah Chai
PLPoh Sim Low
Poh Sim Low
PLPoh San Lai
Poh San Lai

30 November 2014 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
CGChristian A Graves
Christian A Graves
FAFadi F Abboodi
Fadi F Abboodi
STSwati Tomar
Swati Tomar
JWJames Wells
James Wells
LPLucia Pirisi
Lucia Pirisi
Positive markers of epithelial‐mesenchymal transition (EMT) in head and neck cancers complicate clinical management and are associated with reduced survival. We discuss recent translational discoveries in EMT and suggest additional actionable molecular pathways, biomarkers, and clinical agents.

3 May 2019 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
STSwati Tomar
Swati Tomar
RSRaman Sethi
Raman Sethi
PLPoh San Lai
Poh San Lai

1 April 2022 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
STSwati Tomar
Swati Tomar
DKDavid C. Klinzing
David C. Klinzing
Ching Kit ChenChing Kit Chen
Ching Kit Chen
LGLouis Hanqiang Gan
Louis Hanqiang Gan
TMTia Moscarello
Tia Moscarello
RFRoger Foo
Roger Foo
Background: Variable penetrance and late-onset phenotypes are key challenges for classifying causal as well as incidental findings in inherited cardiac conditions. Allele frequencies of variants in ancestry-specific populations, along with clinical variant analysis and interpretation, are critical to determine their true significance. Methods: Here, we carefully reviewed and classified variants in genes associated with inherited cardiac conditions based on a population whole-genome sequencing cohort of 4810 Singaporeans representing Southeast Asian ancestries. Results: Eighty-nine (1.85%) individuals carried either pathogenic or likely pathogenic variants across 25 genes. Forty-six (51.7%) had variants in causal genes for familial hyperlipidemia, but there were also recurrent variants in SCN5A and MYBPC3 , causal genes for inherited arrhythmia and cardiomyopathy, which, despite previous reports, we determined to lack criteria for pathogenicity. Conclusions: Our findings highlight the incidence of disease-related variants in inherited cardiac conditions and emphasize the value of large-scale sequencing in specific ancestries. Follow-up detailed phenotyping and analysis of pedigrees are crucial because assigning pathogenicity will significantly affect clinical management for individuals and their family members.